Home
HelpTest ID PDSUX Drug Screen, Prescription/Over the Counter, Chain of Custody, Random, Urine
Additional Testing Requirements
If urine creatinine is required or adulteration of the sample is suspected, also order, ADLTX / Adulterants Survey, Chain of Custody, Random, Urine.
Specimen Required
Supplies: Chain-of-Custody Kit (T282) containing the specimen containers, seals, and documentation is required.
Specimen Volume: 30 mL
Collection Instructions: Collect a random specimen in the container provided, seal, and submit with the associated documentation to satisfy the legal requirements for chain-of-custody testing.
Additional Information
1. Submitting less than 30 mL will compromise the ability to perform all necessary testing.
2. See Emergency/Overdose.
Forms
1. Chain of Custody Request is included in the Chain-of-Custody Kit (T282).
2. If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.
Secondary ID
62741Useful For
The qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent
Providing, when possible, the identification of all drugs present
This test is not useful for drugs of abuse or illicit drug testing, including benzodiazepines, opioids, barbiturates, cocaine, and amphetamine type stimulants.
This test is not useful for the assessment of therapeutic compliance.
This test is not intended for use in employment-related testing.
Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen by demonstrating that it was under the control of personnel involved with testing the specimen at all times; this control implies that the opportunity for specimen tampering would be limited.
Additional Tests
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| COCH | Chain of Custody Processing | No | Yes |
Special Instructions
Method Name
Gas Chromatography-Mass Spectrometry (GC-MS)
Reporting Name
Drug Scrn, Prescription/OTC, CoC, USpecimen Type
UrineSpecimen Minimum Volume
1.1 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Urine | Refrigerated (preferred) | 14 days |
| Frozen | 14 days | |
| Ambient | 3 hours |
Clinical Information
This test looks for a broad spectrum of prescription and over-the-counter (OTC) drugs. It is designed to detect drugs that have toxic effects, as well as known antidotes or active therapies that a clinician can initiate to treat the toxic effect. The test is intended to help physicians manage an apparent overdose or intoxicated patient, to determine if a specific set of symptoms might be due to the presence of drugs, or to evaluate a patient who might be abusing these drugs intermittently. This test is not appropriate for drugs of abuse or illicit drug testing, including benzodiazepines, opioids, barbiturates, cocaine, and amphetamine type stimulants.
Drugs of toxic significance that are not detected by this test are: digoxin, lithium, and many drugs of abuse or illicit drugs, some benzodiazepines, and some opiates. For these drugs, see Mayo Clinic Laboratories' drug abuse surveys, drug screens, or individual tests.
Chain of custody is a record of the disposition of a specimen to document the personnel who collected it, who handled it, and who performed the analysis. When a specimen is submitted in this manner, analysis will be performed in such a way that it will withstand regular court scrutiny.
See Emergency/Overdose for detection limits for drugs detected in this test.
Reference Values
Drugs detected are presumptive. Additional testing may be required to confirm the presence of any drugs detected.
Cautions
No significant cautionary statements.
Day(s) Performed
Monday through Friday
Report Available
3 to 4 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80307